Bioloomics Inc
Bioloomics Inc, based in Boulder, CO, is a pioneering biotech company focused on developing safer and more effective cancer therapies through the use of target degrading antibodies. They utilize directed evolution in human cells to discover antibody therapeutics that target specific subcellular organelles, leveraging synthetic biology, AI imaging, and robotics to accelerate drug discovery.
With a team of interdisciplinary pioneers experienced in synthetic biology, machine learning, and protein design, Bioloomics aims to create the next generation of antibody scaffolds to address unmet patient needs. Their innovative approach has garnered significant funding, including a recent $8.7 million seed round, to advance their mission of revolutionizing cancer treatment through cutting-edge technology and scientific expertise.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
